Detection of protein-protein interactions by co-immunoprecipitation (Co-IP) asks whether a partner remains associated with an antibody-captured bait after wash (Kaboord and Perr 2008). Protein-protein interactions by co-immunoprecipitation names the same detection task. The assay does not name every protein-protein interaction (PPI) method, chromatin immunoprecipitation, a recombinant pull-down, or a diagnostic test. A positive elution reports co-recovery at the stringency that was used. It does not prove a direct binary interface, a kinetic constant, or a native tissue state. Reciprocal Co-IP and isotype controls decide whether the detection is bait-specific. Closed-pair Western blot and open LC-MS/MS change the searchable partner space, not the capture chemistry.

Researchers who already have a named bait, an immunoprecipitation-capable antibody, or a specific project objective can also review the MtoZ Biolabs Co-IP-MS Protein Interaction Analysis Service for project-specific feasibility and analysis planning.

What a Co-IP Detection Result Can Claim

A closed-pair Western blot asks whether a prechosen prey is present in the bound fraction with the bait. The prey should also be visible in input. Absence from the isotype or bead lane is required before the band is called bait-specific. An open liquid chromatography-tandem mass spectrometry (LC-MS/MS) list asks which proteins survive the same capture after those reagent controls.

Neither readout converts co-recovery into a direct-contact map. A third protein can bridge the pair. Overexpression or a tag can create contacts that the untagged protein does not make. A lysate from cultured cells is not automatically a physiological neighborhood. Disease-pathway language added after the elution is annotation. It does not turn the detection into a therapeutic or diagnostic certificate.

Researchers who need the antibody-capture definition before using Co-IP as a PPI detection assay can refer to What Is Co-Immunoprecipitation (Co-IP)? for more detailed guidance.

Co-IP detects association that survives antibody capture, not a binary interface or a clinical intended use.

How the Detection Assay Is Set Up

Lyse cells or tissue under non-denaturing conditions so complexes that can tolerate the detergent remain intact. An immunoprecipitation-capable antibody binds the bait. Protein A or Protein G beads collect the immune complex. Washes remove unbound lysate. Elution feeds SDS-PAGE plus blot, or digestion for MS.

Antibody performance sets the detection. Western-blot reactivity does not guarantee immunoprecipitation performance. An epitope on the partner interface can block the contact and produce a false negative. Pre-screening the antibody on bait recovery, and on a bait-null or knockdown lysate when available, is part of the detection design.

Wash count trades cleanliness against retention. Extra salt or detergent lowers bead background and also loses weak contacts. Chemical cross-linkers can hold some short-lived pairs before lysis. They also freeze neighbors that were only nearby. Those choices belong in the result sentence. They are not a single locked buffer recipe.

Detection design	Question the elution can answer	Default limit
Co-IP plus prey blot	Does this named prey co-recover with the bait	Direct contact unproven
Reciprocal Co-IP	Does the reverse antibody recover the first bait	Shared epitope or abundance artifacts
Empty IgG or bead capture	What binds the reagent	Not a substitute for a second method
Co-IP-MS	Which proteins remain after matched controls	Contaminant-dominated lists
Condition comparison	Does prey recovery change with treatment	Bait capture must be matched first

Figure 1. Co-IP detection holds the bait with an antibody, then reads a named prey by blot or an open partner list by LC-MS/MS.

When Co-IP Is the Matching Detection Assay

Co-IP fits a closed pair when an immunoprecipitation-capable antibody exists and a prey antibody can test the elution. It fits a validation step after a genetic screen or a proximity list when the paper needs biochemical co-recovery in the same cell system. Co-IP-MS fits an open partner search when the same antibody works and IgG plus bead controls can rank enrichment.

Reassess Co-IP when no usable immunoprecipitation antibody exists, when the needed claim is a kinetic constant or an interface map, or when the question is protein-DNA occupancy. A recombinant pull-down, a sensor assay, or chromatin immunoprecipitation then becomes the matching detection. Reassess Co-IP when the paper needs a large pairwise genetic screen. Yeast two-hybrid or a related reporter is built for that search space.

Condition or treatment comparisons belong on Co-IP only after bait recovery is shown to be matched. A weaker prey band with a weaker bait capture is not a regulated interaction. Semi-quantitative blot densitometry can rank a closed pair across repeats. It still does not report a Kd.

For studies focused primarily on how Co-IP sits among other association assays, Methods for Detecting Protein-Protein Interactions (PPIs) provides a more detailed explanation of genetic reporters, proximity labeling, and biophysical readouts.

In MtoZ Biolabs Co-IP-MS offerings, antibody capture is typically paired with LC-MS/MS identification of co-recovered proteins against matched isotype or bead controls. Service configuration is not an academic rule that other laboratories must copy, and it does not include a diagnostic or GMP release intended use.

Figure 2. Use Co-IP blot for a named prey, Co-IP-MS for an open list, and a different assay when the claim is a direct interface or a kinetic constant.

A detection title does not make Co-IP the default PPI method for every claim.

How a Positive Detection Should Be Read

Read bait recovery in the bound fraction first. If the antigen is missing, prey bands are not interpretable. Input and flow-through show whether the prey was present and whether capture depleted it. A prey that appears in the empty-IgG or bead lane is not bait-specific.

Reciprocal Co-IP raises confidence when both antibodies work. Failure of the reverse assay is data. The second epitope may sit on the contact surface, or one protein may be far more abundant. Agreement across a second method, such as a defined-pair pull-down or a proximity mark, is stronger than repeating the same elution.

A long MS list is a ranked candidate set. Recurrent contaminants and antibody-sticky proteins should be filtered before module or hub language. Pathway cartoons and public-database overlays are annotations added after detection. They do not convert co-recovery into a drug-target certificate.

Frequently Asked Questions

1. Does a Co-IP band prove that two proteins bind directly?

No. Co-recovery can be direct or bridged by a third partner. A defined-pair or interface assay is required for a direct-contact claim.

2. Can Co-IP detect transient or low-abundance interactions by default?

No. Harsh washes lose weak contacts. Low bait or a poor antibody also misses partners. Cross-linking or proximity labeling is the usual reassessment when transience is the claim.

3. Is Western blot required, or can MS replace it?

Blot tests a named prey. MS expands the searchable list after the same capture. The readout follows the question. It does not change the antibody handle.

4. Can Co-IP detection be used as a clinical diagnostic test?

No. A research elution in a defined system is not a diagnostic cutoff. Diagnostic use needs a locked intended use and evidence outside a discovery capture.

Once the bait, antibody status, controls, and Western versus MS endpoint are defined, the project can be evaluated as a Co-IP detection study. Researchers can review the MtoZ Biolabs Co-IP-MS Protein Interaction Analysis Service for project-specific sample evaluation, feasibility assessment, and workflow planning.